Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell-based treatments for gynecological solid tumors.

A Perillo1, G Ferrandina, L Pierelli

  • 1Department of Gynecology and Obstetrics, Catholic University of the Sacred Heart, Rome, Italy.

European Review for Medical and Pharmacological Sciences
|June 11, 2005
PubMed
Summary

Hematopoietic stem cells (HSC) offer promising therapeutic strategies for gynecological cancers and other malignancies. Future research focuses on HSC expansion, cord blood, and gene therapy for enhanced cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiomics-based ultrasOund Model for differentiating Uterine Sarcomas from leiomyomas (ROMUS): a retrospective pilot Multicenter Italian Trials in Ovarian Cancer (MITO) study.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

7 Tesla MRI in Multiple Sclerosis: Insights From Its Use in Clinical Routine.

European journal of neurology·2025
Same author

Endometrioid borderline ovarian tumour: A multicentre analysis from the MITO-14 study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025
Same author

Correlation between radiation dose to bone marrow subregions and acute hematologic toxicity inendometrial cancer treated with external beam radiotherapy.

Clinical and translational radiation oncology·2025
Same author

Hepatic melanomacrophage centers in the arctic cultured fish <i>Cyclopterus lumpus</i> are not indicative of its health state.

Aquaculture (Amsterdam, Netherlands)·2024
Same author

Stereotactic Body Reirradiation in Gynaecological Cancer: Outcomes and Toxicities from a Single Institution Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Immunotherapy

Background:

  • Hematopoietic stem cells (HSC) have been utilized in cancer therapy since the late 1980s, particularly for gynecological cancers.
  • Current applications include autologous HSC transplantation for ovarian cancer and as a source for dendritic cell vaccines.
  • Allogeneic HSC transplantation is explored for non-hematologic malignancies using various conditioning regimens.

Purpose of the Study:

  • To review the current state and future directions of stem cell-based therapies in oncology.
  • To highlight the established and emerging roles of hematopoietic stem cells in cancer treatment.
  • To discuss novel approaches for enhancing stem cell efficacy in cancer therapy.

Main Methods:

  • Review of existing literature on stem cell-based cancer therapies.

Related Experiment Videos

  • Analysis of clinical experiences with autologous and allogeneic HSC transplantation.
  • Exploration of future research avenues in stem cell oncology.

    • Main Results:

    • HSC transplantation is a key supportive therapy in high-dose chemotherapy regimens.
    • HSC can be used for immune-based cancer vaccination strategies.
    • Allogeneic HSC transplantation shows potential as an adoptive immunotherapy for various cancers.

    Conclusions:

    • Future strategies involve ex-vivo HSC expansion, umbilical cord blood utilization, and gene therapy.
    • Cancer stem cell research presents a new frontier for HSC-based therapeutic development.
    • Continued investigation into novel stem cell applications is crucial for advancing cancer treatment.